|
|
Article: FDA Approves New Treatment for Insomnia
- Article from:
- AP Online
- Article date:
- July 23, 2005
CopyrightThis material is published under license from the Associated Press. All inquiries regarding rights should be directed to the Associated Press. (Hide copyright information)
|
AP Online
07-23-2005
Dateline: WASHINGTON
The government approved a new treatment for insomnia on Friday, the first prescription sleep aid not designated as a controlled substance.
Called Rozerem, the drug works differently from its competitors.
Rozerem is chemically related to the natural hormone melatonin, which helps regulate the body's sleep-wake cycle, and is thought to work by stimulating melatonin receptors in the brain, explained Dr. Robert Meyer of the Food and Drug Administration.
"It's another option" for people with the main form of insomnia, difficulty in falling asleep, Meyer said. "By working through a different pathway, it's entirely possible that this might work for some ...
Related newspaper, magazine, and journal articles:
|
|
Article: Takeda Pharmaceuticals North America Names Chief ...
PR Newswire;
November 22, 2005 ;
700+ words
... ... Nov. 22 /PRNewswire/ -- Takeda Pharmaceuticals North America, Inc. (TPNA ... said Mark Booth, president of Takeda Pharmaceuticals North America. "We're pleased ... University of Chicago School of Law. Takeda Pharmaceuticals North America, Inc. Based in ...
|
|